Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history – an open-label randomised trial (the EPPI trial): study protocol

BACKGROUND: Preeclampsia and intrauterine fetal growth restriction (IUGR) are two of the most common causes of maternal and perinatal morbidity and mortality. Current methods of predicting those at most risk of these conditions remain relatively poor, and in clinical practice past obstetric history...

Descripción completa

Detalles Bibliográficos
Autores principales: Groom, K. M., McCowan, L. M., Stone, P. R., Chamley, L. C., McLintock, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120461/
https://www.ncbi.nlm.nih.gov/pubmed/27876004
http://dx.doi.org/10.1186/s12884-016-1162-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120461/
https://www.ncbi.nlm.nih.gov/pubmed/27876004
http://dx.doi.org/10.1186/s12884-016-1162-y

Ejemplares similares